These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28211799)

  • 1. Increased expression of long non-coding RNA GLIDR in prostate cancer.
    Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
    Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.
    Zhang Y; Zhang P; Wan X; Su X; Kong Z; Zhai Q; Xiang X; Li L; Li Y
    Biomed Pharmacother; 2016 Oct; 83():936-941. PubMed ID: 27522256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLIDR promotes the aggressiveness progression of prostate cancer cells by sponging miR-128-3p.
    Li S; Wang Y; Cao Q; Li H; Zhao Z; Wei B; Yuan H; Chen Z; Yang S
    Pathol Res Pract; 2023 Feb; 242():154343. PubMed ID: 36709726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the Long Non-Coding RNA NeSt and FOXCUT in Early Stages of Prostate Cancer Samples as Promising Biomarkers.
    Rostami S; Nabi M; Naghavi P; Mohammadzadeh N; Khalili A
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients.
    Zhao R; Sun F; Bei X; Wang X; Zhu Y; Jiang C; Zhao F; Han B; Xia S
    Prostate; 2017 Jul; 77(10):1107-1117. PubMed ID: 28585762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA SNHG6 is upregulated in prostate cancer and predicts poor prognosis.
    Yan Y; Chen Z; Xiao Y; Wang X; Qian K
    Mol Biol Rep; 2019 Jun; 46(3):2771-2778. PubMed ID: 30911973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
    Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
    Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
    Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
    Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer.
    Bawa P; Zackaria S; Verma M; Gupta S; Srivatsan R; Chaudhary B; Srinivasan S
    PLoS One; 2015; 10(5):e0122143. PubMed ID: 25933431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.